mast cell
Showing 1 - 25 of >10,000
Respiratory Disease, Allergic Diseases and/or Mast Cell
Not yet recruiting
- Allergic Diseases
- +2 more
-
Toulouse, FranceLaurent GUILLEMINAULT
Sep 7, 2023
Mast Cell Activation Syndrome in EDS With Digestive Disorders
Recruiting
- Ehlers Danlos Hypermobile Syndrome
- Determine the presence of mast cell activation syndrome
-
Lille, Nord, FranceSaint-Vincent-de-Paul hospital
Jan 10, 2023
Study of Mast Cell Precursors
Completed
- Mastocytosis
- Healthy Volunteer
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Nov 4, 2022
Study of Factors Regulating Mast Cell Proliferation
Recruiting
- Mastocytosis
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Mast Cell Activation Disease, Mast Cell Activation Syndrome, Mast Cell Disease Trial in Poitiers (Ophthalmological examination)
Recruiting
- Mast Cell Activation Disease
- +3 more
- Ophthalmological examination
-
Poitiers, Nouvelle Aquitaine, FranceMasson Regnault
Apr 12, 2022
Mast Cell Activation Syndrome, Mast Cell Activation Disorder Idiopathic Trial in Weldon Spring, New York, Toronto (FSD201,
Recruiting
- Mast Cell Activation Syndrome
- Mast Cell Activation Disorder Idiopathic
- FSD201
- Placebo
-
Weldon Spring, Missouri
- +2 more
Jan 26, 2023
(PROSPECTOR) Screening Study Evaluating Prevalence of KIT D816V
Recruiting
- Systemic Mast Cell Activation
- KIT D816V Mutation
- Screening
-
Boston, Massachusetts
- +1 more
May 5, 2022
Mast Cell Activation Syndrome Trial in Weldon Spring, Toulouse (Masitinib 4.5 mg/kg/day, Placebo, Best supportive care)
Recruiting
- Mast Cell Activation Syndrome
- Masitinib 4.5 mg/kg/day
- +3 more
-
Weldon Spring, Missouri
- +1 more
Jul 18, 2022
Serum Mast Cell Tryptase Levels to Arthrofibrosis Rates Among
Active, not recruiting
- Knee Osteoarthritis
- +2 more
-
Rochester, MinnesotaMayo Clinic
Jul 27, 2022
Food Allergy Trial in Dublin, London (Intranasal food challenge, Mast cell activation test)
Enrolling by invitation
- Food Allergy
- Intranasal food challenge
- Mast cell activation test
-
Dublin, Ireland
- +1 more
Oct 18, 2023
Aggressive Systemic Mastocytosis, Systemic Mastocytosis-associated Hematologic Non-mast Cell Disease, Mast Cell Leukemia Trial
Completed
- Aggressive Systemic Mastocytosis
- +3 more
-
Stanford, California
- +10 more
Jan 12, 2023
Advanced Systemic Mastocytosis (AdvSM), SM With an Associated Hematologic Tumor (SM-AHN), Mast Cell Leukemia (MCL) Trial in
Recruiting
- Advanced Systemic Mastocytosis (AdvSM)
- +3 more
- CGT9486 tablets
-
Duarte, California
- +10 more
Jul 8, 2022
High-risk MDS, Acute Myelogenous Leukemia, Systemic Mastocytosis Trial in Minneapolis, Madison (GTB-3550 TriKE® Phase I,
Terminated
- High-risk Myelodysplastic Syndromes
- +3 more
- GTB-3550 TriKE® Phase I
- GTB-3550 TriKE® Phase II
-
Minneapolis, Minnesota
- +1 more
Mar 21, 2022
Food Allergy, Food Allergy in Infants, Food Allergy in Children Trial in United Kingdom (Basophil activation test (BAT), Oral
Not yet recruiting
- Food Allergy
- +6 more
- Basophil activation test (BAT)
- Oral food challenge (OFC)
-
Birmingham, United Kingdom
- +10 more
Aug 16, 2022
Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Systemic Mastocytosis With an Associated Hematological Tumor
Approved for marketing
- Advanced Systemic Mastocytosis
- +3 more
- (no location specified)
Oct 5, 2021
Avapritinib Versus Best Available Therapy in Patients With AdvSM
Completed
- Advanced Systemic Mastocytosis
- +3 more
-
Palo Alto, California
- +5 more
Dec 17, 2021
Premature Newborns Trial in Reims (Additional taking blood)
Completed
- Premature Newborns
- Additional taking blood
-
Reims, FranceChu Reims
Mar 30, 2021
Mastocytosis Trial in Cambridge
Completed
- Mastocytosis
-
Cambridge, MassachusettsRegistry participation is worldwide and not limited to this faci
Feb 3, 2021
Burden Disease in Patients With Mast Cell Disorders
Unknown status
- Mastocytosis
- Cutaneous
- Score SMI
-
Toulouse, FranceCristina BULAI LIVIDEANU
Nov 3, 2020
Asthma Trial in Copenhagen (MEDI9929, Placebo)
Completed
- Asthma
- MEDI9929
- Placebo
-
Copenhagen, DenmarkCopenhagen University Hospital Bispebjerg
May 30, 2021
Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Systemic Mastocytosis With an Associated Hematologic Tumor
Active, not recruiting
- Advanced Systemic Mastocytosis
- +3 more
-
Stanford, California
- +31 more
Mar 25, 2022
Mast Cell Activation Test in Allergic Disease
Completed
- Asthma
- +6 more
-
Hong Kong, Hong KongHong Kong Sanatorium & Hospital
Mar 27, 2020
SARS-CoV Infection, COVID-19, Allergic Reaction Trial in United States (Moderna COVID-19 Vaccine, Pfizer-BioNTech COVID-19
Completed
- SARS-CoV Infection
- +3 more
- Moderna COVID-19 Vaccine
- +2 more
-
Tucson, Arizona
- +28 more
Sep 19, 2022
Indolent Systemic Mastocytosis, Monoclonal Mast Cell Activation Syndrome Trial in Worldwide (BLU-263, Placebo)
Recruiting
- Indolent Systemic Mastocytosis
- Monoclonal Mast Cell Activation Syndrome
- BLU-263
- Placebo
-
Palo Alto, California
- +33 more
Jul 27, 2022
Mast Cells and Prognosis in Acute Myocardial Infarction
Not yet recruiting
- Inflammation
- +2 more
- Tryptase
- (no location specified)
Apr 5, 2023